News
-
-
-
-
-
-
-
-
PRESS RELEASE
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2025
2CRSi Group announces monthly voting rights and share capital information as of May 31, 2025, in compliance with French regulations. Specializing in high-performance servers for AI, the company operates globally -
PRESS RELEASE
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2025
2CRSi SA monthly report for May 2025 discloses total shares, voting rights, and AI computing solutions revenue. Listed on Euronext Paris and Euronext Growth -
PRESS RELEASE
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Applied DNA Sciences, Inc. announces the resumption of quarterly investor calls starting mid-August 2025, cancelling the June 17th call. The company focuses on PCR-based DNA technologies